Searchable abstracts of presentations at key conferences in endocrinology

ea0029p578 | Diabetes | ICEECE2012

Frequency and outcome of follow-up testing after a positive gestational diabetes screen

Prosser C , Chik C

Objective: In Edmonton, universal screening of all pregnancies is performed using a 50 g gestational diabetes screen (GDS). Canadian Diabetes Association (CDA) Practice Guidelines recommend a 75 g 2 h oral glucose tolerance test (OGTT) if the GDS glucose result is between 7.8 and 10.2 mmol/l. This study is designed to assess the frequency of OGTT requests in response to a positive GDS and the prevalence of normal OGTT in this population.Methods: All GDS ...

ea0029p575 | Diabetes | ICEECE2012

Effective utilization of anti-GAD measurement

Prosser C. , Grason R. , Chow M.

Introduction: Responsible use of healthcare resources dictates that judicious test ordering be encouraged. Although the appearance of anti-GAD antibodies is known to precede and predict the development of autoimmune diabetes, its use as a screen for risk of developing diabetes is not warranted. Results are useful in determining treatment, however, when it is difficult to distinguish type 1 from type 2 diabetes or when the probability of progression from type 2 to type 1 is hig...